Skip to main content
. 2022 Dec 27;95(1):e28417. doi: 10.1002/jmv.28417

Table 1.

hrHPV positivity within the VALGENT‐2 screening population assessed with OncoPredict HPV® SCR assay and GP5+/6+‐PCR‐EIA

Number screened Number hrHPV+ % hrHPV+
OncoPredict HPV SCR 968 157 16.2%
GP5+/6+‐PCR‐EIA 968 167 17.3%

Abbreviations: HPV, human papillomavirus; hrHPV, high‐risk HPV.